论文部分内容阅读
目的:探究高通血量血液透析在糖尿病肾病患者中的应用效果。方法:选取2011年7月至2014年7月我院收治的糖尿病肾病患者60例,按照透析方法的不同分成两组,每组30例,对照组采用低通量血液透析,观察组采用高通量血液透析,观察两组的应用效果。结果:随访1-3年,观察组1年、3年存活率均明显高于对照组,且观察组心脑血管事件发生率为36.67%,对照组为73.33%,观察组心脑血管事件发生率明显低于对照组,P<0.05,均有统计学意义。结论:高通量血液透析在糖尿病肾病患者中具有较好的应用效果,能够提高患者存活率,降低心脑血管事件发生率,值得在临床上推广。
Objective: To explore the effect of high-pass hemodialysis on patients with diabetic nephropathy. Methods: From July 2011 to July 2014, 60 patients with diabetic nephropathy admitted to our hospital were divided into two groups with 30 patients in each group. The control group received low-flux hemodialysis. The observation group was treated with high-pass Amount of hemodialysis, observe the application effect of two groups. Results: The follow-up of 1-3 years, the observation group 1 year, 3-year survival rates were significantly higher than the control group, and the observation group was 36.67% incidence of cardiovascular and cerebrovascular events, control group was 73.33%, observation group cardiovascular and cerebrovascular events The rate was significantly lower than the control group, P <0.05, all with statistical significance. Conclusion: High-throughput hemodialysis has a good effect in patients with diabetic nephropathy, which can improve the survival rate of patients and reduce the incidence of cardiovascular and cerebrovascular events, which is worth popularizing in clinic.